Comparing the Southern blot method and polymerase chain reaction product analysis for chimeric RCCX detection in CYP21A2 deficiency

Analytical Biochemistry

Volumn 399, Issue 2, 2010, Pages 293-298

  Lee, Hsien Hsiung ^a   Lee, Yann Jinn ^b,c   Chao, Mei Chyn ^d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CAH; Chimeras of the RCCX module; CYP21A2; PCR based amplification; Southern blot analysis

Indexed keywords

GENES;

CHIMERAS OF THE RCCX MODULE; CONGENITAL ADRENAL HYPERPLASIAS; CYP21A2; PCR PRODUCTS; SOUTHERN BLOT; SOUTHERN BLOT ANALYSIS; TAQI ENDONUCLEASE;

POLYMERASE CHAIN REACTION;

CYTOCHROME P450; CYTOCHROME P450 21A2; ENDONUCLEASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CASE REPORT; CHIMERA; CHROMOSOME 6P; CHROMOSOME DELETION; CHROMOSOME STRUCTURE; CONGENITAL ADRENAL HYPERPLASIA; FEMALE; GENE MUTATION; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PSEUDOGENE; RCCX MODULE; SOUTHERN BLOTTING;

EID: 77049092235     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.11.037     Document Type: Article

References (34)

1. Shen L., Wu L.C., Sanlioglu S., Chen R., Mendoza A.R., Dangel A.W., Carroll M.C., Zipf W.B., and Yu C.Y. Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region: molecular cloning, exon-intron structure, composition retroposon, and breakpoint of gene duplication. J. Biol. Chem. 269 (1994) 8466-8476
2. Gitelman S.E., Bristow J., and Miller W.L. Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus. Mol. Cell Biol. 12 (1992) 2124-2134
3. Bristow J., Tee M.K., Gitelman S.E., Mellon S.H., and Miller W.L. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J. Cell Biol. 122 (1993) 265-278
4. Blanchong C.A., Zhou B., Rupert K.L., Chung E.K., Jones K.N., Sotos J.F., Zipf W.B., Rennebohm R.M., and Yu C.Y. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians: the load of RCCX genetic diversity on major histocompatibility complex-associated disease. J. Exp. Med. 191 (2000) 2183-2196
5. Yu C.Y. The complete exon-intron structure of a human complement component C4A gene: DNA sequences, polymorphism, and linkage to the 21-hydroxylase genes. J. Immunol. 146 (1991) 1057-1066
6. Koppens P.F.J., Hoogenboezem T., and Degenhart H.J. Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB-TNXA hybrids in apparent large-scale gene conversions. Hum. Mol. Genet. 11 (2002) 2581-2590
7. Lee H.H., Chang S.F., Tseng Y.T., and Lee Y.J. Identification of the size and antigenic determinants of the C4 gene by a PCR-based amplification method. Anal. Biochem. 357 (2006) 122-127
8. Lee H.H. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module. Mol. Genet. Metab. 84 (2005) 4-8
9. Lee H.H. CYP21 mutations and congenital adrenal hyperplasia. Clin. Genet. 59 (2001) 293-301
10. White P.C., and Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. Rev. 21 (2000) 245-291
11. Burch G.H., Gong Y., Liu W., Dettman R.W., Curry C.J., Smith L., Miller W.L., and Bristow J. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat. Genet. 17 (1997) 104-108
12. Schalkwijk J., Zweers M.C., Steijlen P.M., Dean W.B., Taylor G., van Vlijmen I.M., Van Haren B., Miller W.L., and Bristow J. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N. Engl. J. Med. 345 (2001) 1167-1175
13. Concolino P., Mello E., Minucci A., Giardina E., Zuppi C., Toscano V., and Capoluongo E. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form. BMC Med. Genet. 10 (2009) 72
14. Lee H.H., Lee Y.J., Wang Y.M., Chao H.T., Niu D.M., Chao M.C., Tsai F.J., Lo F.S., and Lin S.J. Low frequency of the CYP21A2 deletion in ethnic Chinese (Taiwanese) patients with 21-hydroxylase deficiency. Mol. Genet. Metab. 93 (2008) 450-457
15. Lee H.H., Chang S.F., Tsai F.J., Tsai L.P., and Lin C.Y. Mutation of IVS2-12 A/C->G in combination with 707-714delGAGACTAC in the CYP21 gene is caused by deletion of the C4-CYP21 repeat module with steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 88 (2003) 2726-2729
16. Lee H.H., Lee Y.J., Chan P., and Lin C.Y. Use of PCR-based amplification analysis as a substitute for the Southern blot method for CYP21 deletion detection in congenital adrenal hyperplasia. Clin. Chem. 50 (2004) 1074-1076
17. Lee H.H. Diversity of the CYP21P-like gene in CYP21 deficiency. DNA Cell Biol. 24 (2005) 1-9
18. Lee H.H., Tsai F.J., Lee Y.J., and Yang Y.C. Diversity of the CYP21A2 gene: a 6.2-kb TaqI fragment and a 3.2-kb TaqI fragment mistaken as CYP21A1P. Mol. Genet. Metab. 88 (2006) 372-377
19. White P.C., Vitek A., Dupont B., and New M.I. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc. Natl. Acad. Sci. USA 85 (1988) 4436-4440
20. Morel Y., Andre J., Uring-Lambert B., Hauptmann G., Betuel H., Tossi M., Forest M.G., David M., Bertrand J., and Miller W.L. Rearrangements and point mutations of P450c21 gene are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia. J. Clin. Invest. 83 (1989) 527-536
21. Morel Y., and Miller W.L. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. In: Harris H., and Hirschhorn K. (Eds). Advances in Human Genetics vol. 20 (1991), Plenum, New York 1-68
22. L'Allemand D., Tardy V., Gruters A., Schnabel D., Krude H., and Morel Y. How a patient homozygous for a 30-kb deletion of the C4-CYP21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 85 (2000) 4562-4567
23. Lee H.H., Lee Y.J., and Lin C.Y. PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module. Genomics 83 (2004) 944-950
24. Lee H.H., Chao H.T., Ng H.T., and Choo K.B. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J. Med. Genet. 33 (1996) 371-375
25. Donohoue P.A., Jospe N., Migeon C.J., and Van Dop C. Two distinct areas of unequal crossing over within the steroid 21-hydroxylase genes produce absence of CYP21B. Genomics 5 (1989) 397-406
26. Stikkelbroeck N.M.M.L., Hoefsloot L.H., de Wijs I.J., Otten B.J., Hermus A.R.M.M., and Sistermans E.A. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. J. Clin. Endocrinol. Metab. 88 (2003) 3852-3859
27. Dain L.B., Buzzalino N.D., Oneto A., Belli S., Stivel M., Pasqualini T., Minutolo C., Charreau E.H., and Alba L.G. Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients. Clin. Endocrinol. 56 (2002) 239-245
28. Koyama S., Toyoura T., Saisho S., Shmozawa K., and Yata J. Genetic analysis of Japanese patients with steroid 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. J. Clin. Endocrinol. Metab. 87 (2002) 2668-2673
29. Kharrat M., Tardy V., M'rad R., Maazoul F., Jemaa L.B., Refaï M., Morel Y., and Chaabouni H. Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J. Clin. Endocrinol. Metab. 89 (2004) 368-374
30. Keen-Kim D., Redman J.B., Alanes R.U., Eachus M.M., Wilson R.C., New M.I., Nakamoto J.M., and Fenwick R.G. Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency). J. Mol. Diagn. 7 (2005) 236-246
31. Loidi L., Quinteiro C., Parajes S., Barreirot J., Leston D.G., Cabezas-Agricola J.M., Sueiro A.M., Araujo-Vilar D., Catro-Feijoo L., Costas J., Pombo M., and Dominguez F. High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations, and a founder effect. Clin. Endocrinol. 64 (2006) 330-336
32. Chu X., Braun-Heimer L., Rittner C., and Schneider P.M. Identification of the recombination site within the steroid 21-hydroxylase gene (CYP21) of the HLA-B27, DR7 haplotype. Exp. Clin. Immunogenet. 9 (1992) 80-85
33. Friaes A., Rego A.T., Aragues J.M., Moura L.F., Mirante A., Mascarenhas M.R., Kay T.T., Lopes L.A., Rodrigues J.C., Guerra S., Dias T., Teles A.G., and Goncalves J. CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions. Mol. Genet. Metab. 88 (2006) 58-65
34. Yang Z., Mendoza A.R., Welch T.R., Zipf W.B., and Yu C.Y. Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module): a mechanism for gene deletions and disease associations. J. Biol. Chem. 274 (1999) 12147-12156